peptide1
General Information
DRACP ID DRACP01597
Peptide Name peptide1
Sequence FLSGIVGMLGKLF
Sequence Length 13
UniProt ID B3KYH4
PubChem CID Not available
Origin analogs of antimicrobial peptide temporin-SHa
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
MCF-7 | Invasive breast carcinoma of no special type | Carcinoma | IC50=14.47 ± 0.57 μM | MTT assay | 24 h | Patent |
HeLa | Human papillomavirus-related endocervical adenocarcinoma | Carcinoma | IC50=18.36 ± 0.92 μM | MTT assay | 24 h | Patent |
NCI-H460 | Lung large cell carcinoma | Carcinoma | IC50=34.49 ± 1.5 μM | MTT assay | 24 h | Patent |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity NIH 3T3: IC50=73.3 ± 0.08 μM
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C67H108N14O15S
Absent amino acids ACDEHNPQRTWY
Common amino acids GL
Mass 159597
Pl 9.7
Basic residues 1
Acidic residues 0
Hydrophobic residues 7
Net charge 1
Boman Index 2590
Hydrophobicity 166.92
Aliphatic Index 142.31
Half Life
Mammalian: 1.1 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 4
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US10550155B2
Patent Title Anticancer peptides
Other Iinformation Granted Patent; Family: 2s / 2ex; Family Jurisdictions: US; Legal Status: Active; Application No: 201815937281; Filed: Mar 27, 2018; Published: Feb 4, 2020; Earliest Priority: Mar 27, 2018; Granted: Feb 4, 2020
Other Published ID US10550155B2